Overview
Hayakazu Sumida practices in Tokyo, Japan. Sumida is rated as a Distinguished expert by MediFind in the treatment of Scleroderma. Their top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Localized Scleroderma, and Polymyositis.
Their clinical research consists of co-authoring 62 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 43 articles in the study of Scleroderma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- SclerodermaSumida isDistinguished. Learn about Scleroderma.
- Systemic Sclerosis (SSc)Sumida isDistinguished. Learn about Systemic Sclerosis (SSc).
- Advanced
- Localized SclerodermaSumida isAdvanced. Learn about Localized Scleroderma.
- Experienced
- Acute Interstitial PneumoniaSumida isExperienced. Learn about Acute Interstitial Pneumonia.
- AngiosarcomaSumida isExperienced. Learn about Angiosarcoma.
- Atopic DermatitisSumida isExperienced. Learn about Atopic Dermatitis.
- Cutaneous T-Cell Lymphoma (CTCL)
- DermatomyositisSumida isExperienced. Learn about Dermatomyositis.
- Enlarged LiverSumida isExperienced. Learn about Enlarged Liver.